Search Results - "Gradishar W"

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

Authors: Coombes RC Howell S Lord SR et al.

Source: Nature communications [Nat Commun] 2023 Aug 07; Vol. 14 (1), pp. 4741. Date of Electronic Publication: 2023 Aug 07.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

Authors: Coombes RC Howell S Lord SR et al.

Source: Nature communications [Nat Commun] 2025 Mar 06; Vol. 16 (1), pp. 2242. Date of Electronic Publication: 2025 Mar 06.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

CAR-T cell signaling dynamics, rational design principles and artificial intelligence for next-generation chimeric antigen receptors.

Authors: Liu X Tong F Zhang J et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jul 08; Vol. 17, pp. 1893076. Date of Electronic Publication: 2026 Jul 08 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1 -Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy.

Authors: Greco, Martina Gebbia, Vittorio Berardi, Rossana et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2042. 15p.

Author Index.

Source: Psycho-Oncology. Mar2021 Supplement S1, Vol. 30, p100-104. 5p.

Subjects: Karst, Authors, Rainwater

A qualitative examination of cognitive behavioral therapy strategies and health management content to reduce fear of cancer recurrence among breast cancer survivors: Results from the FoRtitude study.

Authors: Beeler DM Jeter E Leitzelar BN et al.

Source: Journal of health psychology [J Health Psychol] 2026 Mar; Vol. 31 (3), pp. 1164-1178. Date of Electronic Publication: 2025 Jul 28.

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

Journal Info: Publisher: Sage Publications Country of Publication: England NLM ID: 9703616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7277 (Electronic) Linking ISSN: 13591053 NLM ISO Abbreviation: J Health Psychol Subsets: MEDLINE

Real‐World Practice Patterns in Diagnosis and First‐Line Treatment in Metastatic Breast Cancer.

Authors: Manohar, Poorni M. Shankaran, Veena Davidson, Nancy E. et al.

Source: Breast Journal. 6/28/2026, Vol. 2026, p1-9. 9p.

Acceptability of the Fit2ThriveMB mHealth physical activity promotion intervention in women with metastatic breast cancer.

Authors: Starikovsky J Solk P Desai R et al.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2025 Jan 06; Vol. 33 (1), pp. 72. Date of Electronic Publication: 2025 Jan 06.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Anthropometric and biochemical nutritional indicators and survival in women with breast cancer: A retrospective cohort study.

Authors: Sánchez-Saldaña, Lourdes Lozada-Urbano, Michelle Sullcahuaman-Allende, Yasser et al.

Source: PLoS ONE. 2/12/2026, Vol. 21 Issue 2, p1-14. 14p.

Real‐World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T‐DM1) in HER2‐Positive Breast Cancer: A Prospective Single‐Institution Study From India.

Authors: Gandrala, Divya Rajappa, Senthil J. Mallavarapu, Krishnamohan et al.

Source: International Journal of Breast Cancer. 4/20/2026, Vol. 2026, p1-8. 8p.

Comparative efficacy of subsequent-line therapies for advanced triple-negative breast cancer: a bayesian network meta-analysis.

Authors: Xu, Zheng Ding, Linxian Zhao, Tai et al.

Source: Oncology Reviews. 2026, p1-12. 12p.

Impact of Neoadjuvant Immunochemotherapy on Surgical Outcomes in Management of Early Triple‐Negative Breast Cancer.

Authors: Khadrouche, Tamasine Morisseau, Mathilde Selmes, Gabrielle et al.

Source: Breast Journal. 7/17/2026, Vol. 2026, p1-9. 9p.

Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.

Authors: Goldvaser, Hadar Khutsurauli, Salome Buchinger, Michele et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2077. 16p.

Efficacy of AC‐T Versus TAC Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Retrospective Analysis.

Authors: Mirzania, Mehrzad Anari, Fatemeh Emami, Seyed Amir Hossein et al.

Source: International Journal of Breast Cancer. 6/19/2026, Vol. 2026, p1-9. 9p.

Post-CDK4/6 Inhibitor Therapeutic Approaches in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Current Evidence and Emerging Strategies—A Narrative Review.

Authors: Al-Shamsi, Humaid O. Abdelwahed, Nadia Abdelwahab, Siddig Ibrahim et al.

Source: Diagnostics (2075-4418). Jun2026, Vol. 16 Issue 12, p1790. 26p.

The impact of VUS reclassification on reproductive decision making.

Authors: Peyser, Alexandra Onel, Kenan Hershlag, Avner

Source: PLoS ONE. 5/27/2025, Vol. 20 Issue 5, p1-8. 8p.

Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study.

Authors: Ricciardi, Giuseppina Rosaria Rita Russo, Alessandro Sanò, Maria Vita et al.

Source: Cancers. Jul2025, Vol. 17 Issue 13, p2069. 11p.

Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer.

Authors: Chung, Erika Z. Alberico, David Sannachi, Lakshmanan et al.

Source: PLoS ONE. 5/27/2026, Vol. 21 Issue 5, p1-15. 15p.

Incidence of frailty-related fracture among Medicaid beneficiaries living with HIV and cancer: A cohort study.

Authors: Zhang, Xueer Rudolph, Jacqueline E. Zhou, Yiyi et al.

Source: PLoS ONE. 5/21/2026, Vol. 21 Issue 5, p1-9. 9p.

LncRNA PGM5-AS1 inhibits the progression of breast cancer by inhibiting miR-182-5p.

Authors: Zhang, Yonghui Chen, Mingxi Zheng, Xuan et al.

Source: Nucleosides, Nucleotides & Nucleic Acids. 2026, Vol. 45 Issue 5, p468-481. 14p.